Position in JNJ
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$68,396,914
-$3,978,347 QoQ
Shares Held
269,311
-9.0% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.81%
of 13F equity value
Holder Rank
#379
of 4,676 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 23%
Shared 0%
None 77%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026YOUSIF CAPITAL MANAGEMENT, LLC holds $293,560,933 across 14 Drug Manufacturers - General names. JNJ ranks #2 (23.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
67,889 | $81,428,110 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
269,311 | $68,396,914 | |
| 3 | ABBV |
AbbVie Inc.
|
202,369 | $50,924,135 | |
| 4 | MRK |
Merck & Co., Inc.
|
226,047 | $29,047,039 | |
| 5 | AMGN |
Amgen Inc
|
51,233 | $18,552,493 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
120,084 | $15,171,412 | |
| 7 | PFE |
Pfizer Inc
|
525,468 | $12,653,269 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
194,129 | $11,185,712 |
All Filings in JNJ
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $68,396,914 | 269,311 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $72,375,261 | 296,086 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $64,249,697 | 310,460 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $59,362,027 | 320,149 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $50,512,897 | 330,690 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $55,891,396 | 337,020 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $48,315,083 | 334,083 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $56,286,679 | 347,320 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $51,304,352 | 351,015 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $56,125,653 | 354,799 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $55,911,195 | 356,713 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $57,323,943 | 368,051 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $66,677,580 | 402,837 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $61,344,040 | 395,768 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $73,931,558 | 418,520 | Shares | Sole | 2023-01-09 | |
| 2022-09-30 | $68,066,884 | 416,668 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $73,574,877 | 414,483 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $76,275,538 | 430,376 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $71,627,522 | 418,703 | Shares | Sole | 2022-01-31 | |
| No filing history on record for this holder in this stock. | ||||||